Sort
21,453 grants matching “tuberculosis”
PREPARE: Post-Baccalaureate Research Education Program and Retention Enhancement
$262,063Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · R25 · FY2007 · GM
Research & training:improve quality of care for neurological disorders in Uganda
$262,062Elly T Katabira · Makerere University College Of Health Sciences · R25 · FY2014 · NS
Genome-scale tracking of Mycobacterium tuberculosis VapC toxins
$262,014Nancy Ann Woychik · Rbhs-Robert Wood Johnson Medical School · R21 · FY2018 · AI
Identification of Mycobacterium tuberculosis-derived metabolites acting as ligands for MR1-restricted T cells.
$262,000Charles Kyriakos Vorkas · State University New York Stony Brook · R21 · FY2023 · AI
STRUCTURE BASED DRUG DESIGN
$261,996University Of California San Francisco · R01 · FY2004 · CA
TUBERCULOSIS PREVENTION AND CONTROL COOPERATIVE AGREEMENT
$261,894Sherry Ketemepi · Baltimore City Health Department · U52 · FY2013 · PS
Conformational dynamics and allosteric regulation during stress-responsive metallocofactor assembly
$261,891Patrick Frantom · University Of Alabama In Tuscaloosa · R01 · FY2015 · GM
Indigenous HIV/AIDS Research Training(IHART2)Program
$261,877Karina Lynn Walters · University Of Washington · R25 · FY2016 · MH
Feedback regulation and transcirptional coupling in bacterial stress-response
$261,733Oleg Igoshin · Rice University · R01 · FY2012 · GM
CAP: Preclinical Development of a TB Therapy Targeting Host Eicosanoid Pathway
$261,555Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Supp to: Strategies for Providing Antiretroviral Therapy to Infants Shortly Afte
$261,549Avy Violari · Wits Health Consortium (Pty), Ltd · U19 · FY2011 · AI
CIPRA-SA: Safeguard the household: comprehensive AIDS research: Extension
$261,549James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U19 · FY2011 · AI
Initiating translation in mycobacteria: ribosome complexity in a leaderless bacterium
$261,486Keith M Derbyshire · Wadsworth Center · R21 · FY2019 · AI
DEVELOPMENT OF INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS DNA REPLICATION
$261,439Michelle M. Butler · Microbiotix, Inc · R43 · FY2007 · AI
Molecular Biology of Mycobacteria and Their Phages
$261,369University Of Pittsburgh At Pittsburgh · R01 · FY2002 · AI
Project 3: Arsenic Biomarker Epidemiology
$261,312Martyn T Smith · University Of California Berkeley · P42 · FY2012 · ES
Innovative Approaches for TB Control in Brazil
$261,250Richard E Chaisson · Johns Hopkins University · U2R · FY2006 · TW
Fluidigm BioMark HD MX/HX Real-Time PCR System
$261,191Shirley Luckhart · University Of California At Davis · S10 · FY2013 · OD
Clinical development of SQ109 for MDR-TB
$261,175Gary Horwith · Sequella, Inc. · R34 · FY2011 · AI
Sustainable One Health Research Training Capacity: Molecular Epidemiology of Zoonotic Foodborne and Waterborne Pathogens in Eastern Africa
$261,131Wondwossen A. Gebreyes · Ohio State University · D43 · FY2017 · TW
Leveraging immunostimulatory pathways that enhance BCG vaccination for the rational design of synthetic neonatal vaccine formulations
$261,000Evan Alexander Scott · Northwestern University · R21 · FY2019 · AI
Myocardial Fibrosis and Steatosis Burden and Region-Specific Predictors of Progression among ART-treated Women with HIV infection in sub-Saharan Africa (The MUTIMA Study)
$260,998Chris Todd Longenecker · University Of Washington · R01 · FY2025 · HL
Development of Probodies: A Novel Class of Therapeutic Antibodies Combining Targe
$260,910James W West · Cytomx Therapeutics, Inc. · R43 · FY2009 · CA
NEW CLASS OF ANTITUBERCULOSIS AMIDES:PRECLINICAL DEVELOP
$260,900National Jewish Health · R21 · FY2001 · AI
HIV, AIDS and Opportunistic Infections
$260,868Vinayaka R Prasad · Albert Einstein College Of Medicine · T32 · FY2013 · AI